Tag Archive for Nature’s Sunshine

Nature’s Sunshine Products Reports Third Quarter 2014 Results

 
Nature’s Sunshine Products, a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, reported its financial results for the third quarter and declared a quarterly cash dividend of $0.10 per share.
“The third quarter reflected continued positive momentum in several key areas of our business which was offset by continued declines our NSP Russia, Central and Eastern Europe business,” commented Gregory L. Probert, Chairman and Chief Executive Officer. “Importantly, Synergy posted its fifth consecutive record setting sales quarter driven by strength in South Korea, Japan, and a return to growth in Europe.”
“Strong distributor leadership in these key markets combined with sustained momentum since last year’s global summit and launch of the SLMsmart weight management program continue to be strong contributors of growth. Sales in NSP North America have begun to improve with NSP United States and NSP Canada posting net sales growth for the first time since the second quarter of 2013 and the first quarter of 2012, respectively.”
“We remain cautiously optimistic about the future of this core market as our new products and sales programs continue to gain traction. We are confident in our ability to leverage science-based innovation

Read more...

Nature’s Sunshine Names Richard Zhang And Henry Zhou As Managing Directors, China

 
Nature’s Sunshine Products, Inc., a leading natural health and wellness company engaged in the manufacture and direct sale of premium-quality nutritional and personal care products, announced the appointment of Richard Zhang as Managing Director, China for Nature’s Sunshine Products (“NSP”), and the appointment of Henry Zhou as Managing Directors, China.

“I am confident that Mr. Zhang and Mr. Zhou will be excellent additions to our growing leadership team in China,” said Gregory L. Probert, Nature’s Sunshine Products’ Chairman and CEO. “Both gentlemen are uniquely qualified to help lead our growth in this key market, bringing rich experiences in direct selling and consumer products as well as developing and managing business in China.”
“We are confident that their combined leadership will help ensure the successful launch of our Nature’s Sunshine-branded products in retail locations across China and Synergy-branded products through a direct selling model. I look forward to embarking on this journey to expand our Distributor and consumer bases and product lines into this region through our multi-brand, multi-channel go-to-market strategy.”

“I am thrilled to have Mr. Zhang and Mr. Zhou join our team to execute our China strategy,” added Paul Noack, Nature’s Sunshine Products’ President of China and New Markets. “I look

Read more...

Nature’s Sunshine Appoints Paul Noack President Of China And New Markets

 
 
Nature’s Sunshine Products, Inc., a leading natural health and wellness company engaged in the manufacture and direct sale of premium-quality nutritional and personal care products, announced the appointment of Paul Noack as President of China and New Markets. Mr. Noack has extensive experience in direct selling and the consumer products industry and will play an instrumental role in managing Nature’s Sunshine Products’ (“NSP”) entry into China through its strategic alliance with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”), as well as the Company’s global expansion strategy in new and emerging markets.
Prior to joining Nature’s Sunshine Products, Mr. Noack served as President of ViSalus, Inc., a direct-to-consumer personal health products company. While at ViSalus, he was responsible for the execution of the Company’s international expansion strategy. Mr. Noack successfully launched ViSalus’ operations into European markets and established a European hub to manage sales, marketing and operations in Western and Central Europe. He further directed the turnaround of ViSalus’ Canadian business, helping it to achieve record sales during his tenure. In addition to his duties as President, Mr. Noack served as a Consultant for ViSalus in 2011, in which he evaluated key opportunities and risks to identify attractive markets for international

Read more...

Dr. Nigel Gericke Joins Nature’s Sunshine Products’ Medical And Scientific Advisory Board

 
Nature’s Sunshine Products, Inc., a leading natural health and wellness company engaged in the manufacture and direct sale of premium-quality nutritional and personal care products, announced that Dr. Nigel Gericke of Cape Town, South Africa, has joined Nature’s Sunshine Products’ (“NSP”) Medical and Scientific Advisory Board. Dr. Gericke is a medical doctor, ethnobotanist and ethnopharmacologist specializing in documentation, discovery, innovation and unique product development from medicinal and food plants. He has a particular interest in phytochemicals that impact the central nervous system and in finding solutions for tropical diseases including malaria. As part of serving on this board, Dr. Gericke will assist with research activities, educate and train NSP and Synergy distributors, and speak at various company events.
“We look forward to working with Dr. Gericke and leveraging his expertise in developing emotional and physical well-being products from medicinal and food plants,” said Gregory L. Probert, Nature’s Sunshine Products’ Chairman and CEO.
Dr. Matt Tripp, NSP’s Chief Scientific Officer, added, “Dr. Gericke has conducted extensive research on indigenous African plants for over two decades and is an expert on everything from their use as botanical foods and medicine to development and commercialization, isolating active compounds, examining molecular biology and directing clinical studies

Read more...

Nature’s Sunshine Announces Closing Of Strategic Alliance With Fosun Pharma

 
Nature’s Sunshine Products, Inc. a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today announced the closing of its previously announced China joint venture with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and private placement transaction of 2.854 million shares of common stock, representing approximately 15% of Nature’s Sunshine’s outstanding common shares, to Fosun Pharma at a price of $16.19 per share. Aggregate proceeds to Nature’s Sunshine were approximately $46.2 million.
“Our strategic alliance with Fosun Pharma is the first of its kind between a U.S. company and a Chinese company for direct selling products in China,” commented Gregory L. Probert, Chairman and Chief Executive Officer of Nature’s Sunshine Products. “Our entry into China marks the beginning of a valuable long-term partnership with Fosun Pharma, as well as a significant step forward as a global organization. As part of our go-to-market strategy, we are focused on completing the regulatory approvals process, establishing the necessary legal entities, recruiting key staff, and moving forward with products to market through a multi-brand, multi-channel approach. We look forward to working with Fosun Pharma to capture the vast opportunity ahead.”
The joint venture, known as Nature’s

Read more...

Nature’s Sunshine To Enter China Through Joint Venture

 
Nature’s Sunshine Products has announced plans to enter China in a joint venture with Shanghai-based Fosun Pharma. The agreement outlines a multi-channel approach that places Nature’s Sunshine products in Fosun Pharma retail locations across the country and markets the company’s Synergy brand through a direct selling model.
Fosun Pharma will acquire a 15 percent stake in Nature’s Sunshine in a deal valued at just over $46 million. As a part of the agreement, Nature’s Sunshine will appoint one Fosun Pharma director to its board. The investment in Nature’s Sunshine will also fund a special $1.50 per share cash dividend to be paid out at closing.
The company expects that Nature’s Sunshine Hong Kong will drive long-term growth and become a top market within five years, says Chairman and CEO Gregory L. Probert.
“We view this joint transaction as both a testament to the strength of our existing business as well as Fosun Pharma’s confidence in our ability to establish a substantial business in China,” Probert said in a statement. “It marks a significant step forward in our transformation to a global organization with multiple brands and distribution channels.”
About Nature’s Sunshine Products
Nature’s Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes

Read more...